EFDID: 139675EFD: View Filing

Issuer: AntriaBio, Inc. (0001509261) - D

Accession: 0001140361-15-015335 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    AntriaBio, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2010)
  • Address:
    1450 Infinite Drive
    Louisville, CO 80027
  • Persons:
    Related Persons 5
    Nevan Charles Elam
    Executive Officer, Director
    Hoyoung Huh
    Director, Executive Officer
    Barry Sherman
    Director
    Sankaram Mantripragada
    Executive Officer
    Morgan Lynn Fields
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    04/14/2015
  • First Sale Date:
    03/31/2015
  • Offering Amount:
    $4,702,703
  • Amount Sold:
    $1,984,012
  • Amount Remaining:
    $2,718,691
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Unit = 1 common share and 1 common share purchase warrant.
  • Sales Clarification:
    Aggregate offering includes amount that may be received by Issuer upon exercise of warrants. Each warrant may be exercised for one common share at a price of $2.50 per share for a period of 36 months from date of issuance.
EFD: Current State Notices

Notices found in EFD

Filed:GA, MD, NJ, TX
Inactive:IL
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Paulson Investment Company, Inc. 5670 None None CA, FL, GA, IL, MD, NJ, NY, TX
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
AntriaBio, Inc./s/ Morgan Lynn FieldsMorgan Lynn FieldsChief Accounting Officer2015-04-14